(0)
NEW YORK, NY / ACCESSWIRE / April 22, 2021 / Qrons Inc. (OTCQB:QRON), an innovative biotechnology company developing next generation treatments for unmet neuronal diseases, using tissue engineering, stem cells and machine learning synergic technologies is proud to report that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,954,315 to the Trustees of Dartmouth College which is directed to mechanically interlocked ,molecules-based materials for 3-D printing. The patents inventors are Professor Chenfeng Ke, a member of Qrons Scientific Advisory Board and Qianming Lin, Professor Ke's assistant.
Since July 2018, Qrons has conducted research with Professor Ke under a Sponsored Research Agreement with Dartmouth to develop innovative 3D printable hydrogels, biocompatible advanced materials as a component of its stem cell-based traumatic brain injury treatment. In October 2019, Qrons entered into an Intellectual Property License Agreement with Dartmouth for an exclusive world-wide license of intellectual property related to 3D printable materials in the fields of human and animal health. This patent grant is the culmination of that process.